Tag: Merck

Merck and Ridgeback to Present Data Demonstrating That Treatment With LAGEVRIO™ (molnupiravir) Was Associated With More Rapid Elimination of Infectious SARS-CoV-2 Than Placebo

Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics today announced...

Merck Provides U.S. and Japan Regulatory Update for Gefapixant

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S....

OMS: Tratamiento de la farmacéutica Merck en pastillas puede ser nueva arma anti COVID

La Organización Mundial de la Salud (OMS) señaló este martes que está estudiando los datos de eficacia...

Merck informó que su pastilla contra la COVID-19 redujo a la mitad las muertes y hospitalizaciones

La farmacéutica Merck & Co. informó hoy que su pastilla experimental contra el coronavirus redujo a la...

Want to stay up to date with the latest news?

We would love to hear from you! Please fill in your details and we will stay in touch. It's that simple!